Nicolas Leupin, M.D., Ph.D.

Nicolas Leupin, M.D., Ph.D.Chief Medical Officer and Member of the Management Board

Nicolas Leupin, M.D., Ph.D., is Chief Medical Officer of Molecular Partners. Nicolas is a medical oncologist with a proven track record in drug development, most recently as Chief Medical Officer of argenx, a clinical-stage biotechnology company developing antibody-based therapies for treatment of severe autoimmune diseases and cancer. In that role he led the company’s global clinical strategy and execution, successfully supporting the company’s transformation into a late-stage clinical company, and was responsible for translating preclinical hypotheses into innovative proof-of concept clinical trials. Prior to argenx, Nicolas held roles of increasing responsibility at Celgene, where he supported the clinical development of several drug candidates in lymphoma and multiple myeloma, resulting in regulatory filings in Europe and the U.S.